Olivier Humbert
Olivier Humbert
PU-PH, Centre Antoine Lacassagne, université Côte d'Azur, Nice
Adresse e-mail validée de
Citée par
Citée par
Deep learning techniques for automatic MRI cardiac multi-structures segmentation and diagnosis: is the problem solved?
O Bernard, A Lalande, C Zotti, F Cervenansky, X Yang, PA Heng, I Cetin, ...
IEEE transactions on medical imaging 37 (11), 2514-2525, 2018
In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic …
L Berthet, A Cochet, S Kanoun, A Berriolo-Riedinger, O Humbert, ...
Journal of Nuclear Medicine 54 (8), 1244-1250, 2013
18F-FDG PET/CT for staging and restaging of breast cancer
D Groheux, A Cochet, O Humbert, JL Alberini, E Hindié, D Mankoff
Journal of Nuclear Medicine 57 (Supplement 1), 17S-26S, 2016
Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphoma
S Kanoun, C Rossi, A Berriolo-Riedinger, I Dygai-Cochet, A Cochet, ...
European journal of nuclear medicine and molecular imaging 41, 1735-1743, 2014
GridNet with automatic shape prior registration for automatic MRI cardiac segmentation
C Zotti, Z Luo, O Humbert, A Lalande, PM Jodoin
Statistical Atlases and Computational Models of the Heart. ACDC and MMWHS …, 2018
Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F] FDG PET to predict survival in Hodgkin lymphoma
S Kanoun, I Tal, A Berriolo-Riedinger, C Rossi, JM Riedinger, ...
PloS one 10 (10), e0140830, 2015
Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes
O Humbert, A Berriolo-Riedinger, JM Riedinger, B Coudert, L Arnould, ...
Annals of oncology 23 (10), 2572-2577, 2012
Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients
C Rossi, S Kanoun, A Berriolo-Riedinger, I Dygai-Cochet, O Humbert, ...
Journal of Nuclear Medicine 55 (4), 569-573, 2014
Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors
L Berland, S Heeke, O Humbert, A Macocco, E Long-Mira, S Lassalle, ...
Journal of thoracic disease 11 (Suppl 1), S71, 2019
18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns
O Humbert, N Cadour, M Paquet, R Schiappa, M Poudenx, D Chardin, ...
European Journal of Nuclear Medicine and Molecular Imaging 47, 1158-1167, 2020
18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations
A Cochet, I Dygai-Cochet, JM Riedinger, O Humbert, A Berriolo-Riedinger, ...
European journal of nuclear medicine and molecular imaging 41, 428-437, 2014
HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy
O Humbert, A Cochet, JM Riedinger, A Berriolo-Riedinger, L Arnould, ...
European journal of nuclear medicine and molecular imaging 41, 1525-1533, 2014
Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors
A Cochet, S Pigeonnat, B Khoury, JM Vrigneaud, C Touzery, ...
Journal of Nuclear Medicine 53 (4), 512-520, 2012
Role of positron emission tomography for the monitoring of response to therapy in breast cancer
O Humbert, A Cochet, B Coudert, A Berriolo-Riedinger, S Kanoun, ...
The oncologist 20 (2), 94-104, 2015
Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer
O Humbert, A Berriolo-Riedinger, A Cochet, M Gauthier, C Charon-Barra, ...
European journal of nuclear medicine and molecular imaging 41, 416-427, 2014
Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
O Humbert, JM Riedinger, C Charon-Barra, A Berriolo-Riedinger, ...
Clinical Cancer Research 21 (24), 5460-5468, 2015
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study
D Chardin, M Paquet, R Schiappa, J Darcourt, C Bailleux, M Poudenx, ...
Journal for immunotherapy of cancer 8 (2), 2020
Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective …
X Duval, V Le Moing, S Tubiana, M Esposito-Farèse, E Ilic-Habensus, ...
Clinical Infectious Diseases 73 (3), 393-403, 2021
Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in …
E Lopci, RJ Hicks, A Dimitrakopoulou-Strauss, L Dercle, A Iravani, ...
European journal of nuclear medicine and molecular imaging 49 (7), 2323-2341, 2022
Dissociated response in metastatic cancer: an atypical pattern brought into the spotlight with immunotherapy
O Humbert, D Chardin
Frontiers in Oncology 10, 566297, 2020
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20